It is an editor's brief statement of the essential features of the measure as introduced. Directs Child Development and Rehabilitation Center of Oregon Health Sciences University to conduct study of hormone secretin as treatment for autism. Appropriates moneys from General Fund to Oregon Department of Administrative Services for purpose of study. Declares emergency, effective on passage. It is a spectrum disorder with mild to severe levels of disability.
Autism affects each individual differently.
Autism includes significant to profound disabilities in functions of the brain, often with unusually high and low splintering of skills. Developmental and skill learning sequences are often notably distorted. Secretin is a neurotransmitter peptide and one of the hormones that controls digestion. There is growing evidence of a decrease in symptoms of autism in children after they received secretin. The use of secretin appears to be a promising treatment for autism.